Smart device applications which are revolutionising healthcare for those with chronic conditions
Related posts: Rare Diseases – A Growing Focus for Healthcare Product Developers Top Ten Health Economics Journals in 2020 Drug…
making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
Thank you very much for all your hard work and enthusiasm in helping us reach acceptance of the manuscript.
The research was very thorough and the concepts were integrated in a very sophisticated manner. Also the writing style was very smooth and comprehensible and very easy for me to work from.
Thank you so much for having your internal reviewers edit these posters. I must say that I was very impressed with their findings, edits, and scientific acumen!
Thanks again. You did an awesome job with the poster!
Let me express my special thanks to Josh and Hannah. You guys were great partners, we owe you a lot!
This is a beautifully written paper and provides a prospective that is rarely addressed in the field of AD. Thank you for including me in this work.
An ISPOR webinar will take place on May 26th from 10:00 AM to 10:45 AM EDT. It is part of ISPOR’s Pathways to Leadership series showcasing HEOR professionals. This webinar will feature Dr. Bertalan […]
According to a national poll, Americans think that reducing drug prices is one of the top priorities at the federal level. A new report explores the consequences that reference pricing would bring, […]
The AMCP (Academy of Managed Care Pharmacy) held a virtual meeting for healthcare professionals, payers, researchers, and pharma companies in September 2020. A new article discusses key points […]
Related posts: Rare Diseases – A Growing Focus for Healthcare Product Developers Top Ten Health Economics Journals in 2020 Drug…
Related posts: How to Spot Predatory Science Reimagining the Office During COVID-19 Home schooling? Not what I thought. Top ten…
Related posts: Anti-Viral Drugs In Development For COVID-19 The World’s Response to SARS-CoV-2 Drug Shortages: New Light on an Old…
Related posts: The World’s Response to SARS-CoV-2 Top 5 Chronic Conditions Affecting the Global Population Does online learning have a…
Related posts: How to Spot Predatory Science Reimagining the Office During COVID-19 Is Medical Education Failing Our Future Doctors? Home…
2020—what a year! In what’s been the deadliest health crisis we’ve seen for some time and hospitals around the world…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.